The validation of the drug delivery platform has significance not only for the in-house drugs being developed but also for collaboration with other organisations within the pharmaceutical sector. Discussions will continue to progress with parties who show interest in this technology.
Translated that means that those collaborators waited for data confirmation which has come in positive.
Now discussions/ negotiations can move to the next level.
The price is at target position, the research data provides strength for the PYC management to push for good conditions.
These licence deal negotiations are far reaching and very consequential and usually take 4 to 6 months.
3 to 4 months down, 2 to 3 to go, as I see it.
all IMO
PYC Price at posting:
15.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)